Exploring pain management preferences: a discrete choice experiment on cannabis or opioids among middle-aged and older adults
- PMID: 40611345
- PMCID: PMC12225370
- DOI: 10.1186/s41043-025-00989-x
Exploring pain management preferences: a discrete choice experiment on cannabis or opioids among middle-aged and older adults
Abstract
Objective: The study examines middle-aged and older adult’s preferences to identify policies that might increase the use of cannabis rather than opioids for controlling physical pain.
Method: A discrete choice survey was administered to 301 older adults (≥ 40 years) in three California regions (Los Angeles, Bay Area, and San Joaquin Valley). Participants expressed preferences for pain medication under mild, moderate, and severe pain scenarios. Each participant made 16 choices between options that varied by medication type (medical cannabis, opioids, over-the-counter medications, or none), effectiveness, accessibility, side effects, addictiveness, and cost of the medication. A conditional logit model (CLM) was used to analyze the results for the entire sample, stratified by pain levels, and according to whether the participant had previous experience with taking medications for physical pain.
Results: The results suggest that, all else equal, over-the-counter (OTC) treatments were the most preferred option for pain management. However, individuals were also willing to consider cannabis as a secondary treatment. Respondents with previous cannabis experience, either medically or recreationally, were more likely to select cannabis as their primary treatment choice. Marginal analysis revealed that the policy option of doubling opioid costs led to the greatest reduction in opioid use and increased the likelihood of cannabis use.
Conclusions: Cannabis is a viable alternative to opioids for controlling pain. Findings suggest that interest in cannabis relative to opioids is high, and that messages that emphasize the addictiveness of opioids relative to cannabis might be particularly effective in decreasing opioid use.
Keywords: Cannabis; Discrete choice experiment; Opioids; Over-the-counter medication; Policy options.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was approved by a university Institutional Review Borad. The project was ruled ‘exempt’. Consent for publication: There is no external consent needed. All authors consent. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials.BMJ Open. 2024 Jan 3;14(1):e068182. doi: 10.1136/bmjopen-2022-068182. BMJ Open. 2024. PMID: 38171632 Free PMC article.
-
Women's Preferences and Willingness to Pay for AI Chatbots in Women's Health: Discrete Choice Experiment Study.J Med Internet Res. 2025 Jun 10;27:e67303. doi: 10.2196/67303. J Med Internet Res. 2025. PMID: 40493513 Free PMC article.
-
Patients' preferences for primary health care - a systematic literature review of discrete choice experiments.BMC Health Serv Res. 2017 Jul 11;17(1):476. doi: 10.1186/s12913-017-2433-7. BMC Health Serv Res. 2017. PMID: 28697796 Free PMC article.
-
Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete-choice experiment.Headache. 2025 Jun 24. doi: 10.1111/head.14974. Online ahead of print. Headache. 2025. PMID: 40552555
-
Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study.Cannabis Cannabinoid Res. 2024 Jun;9(3):e859-e869. doi: 10.1089/can.2022.0248. Epub 2023 Mar 24. Cannabis Cannabinoid Res. 2024. PMID: 36961410 Free PMC article.
References
-
- Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001–02. Vital Health Stat 13. 2006;(159):1–66. Available from: https://stacks.cdc.gov/view/cdc/6677 - PubMed
-
- Centers for Disease Control and Prevention. CDC Clinical Practice Guideline for prescribing opioids for pain - United States, 2022. November 3, 2022. 10.15585/mmwr.rr7103a1
-
- Chou R, Deyo R, Friedly J, et al. Systemic Pharmacologic therapies for low back pain: a systematic review for an American college of physicians clinical practice guideline. Ann Intern Med. 2017;166(7):480–92. 10.7326/M16-2458 - PubMed
-
- Qaseem A, Wilt TJ, McLean RM, Forciea MA. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American college of physicians. Ann Intern Med. 2017;166(7):514–30. 10.7326/M16-2367 - PubMed
LinkOut - more resources
Full Text Sources